US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Exchange Bank (Santa Rosa, CA)

147.40

+0.40000.27%

Volume:210

Turnover:31.02K

Market Cap:252.69M

PE:7.93

High:148.00

Open:148.00

Low:147.40

Close:147.00

52wk High:150.82

52wk Low:102.80

Shares:1.71M

Float Shares:836.00K

Volume Ratio:0.59

T/O Rate:0.03%

Dividend:5.20

Dividend Rate:3.53%

EPS(TTM):18.59

EPS(LYR):17.48

ROE:9.79%

ROA:0.97%

PB:0.72

PE(LYR):8.43

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Enveric says EB-003 shows no phototoxicity risk in preclinical analysis

Exchange Bank Announces Promotion of Mindy Smith to Community Relations Officer

THOMSON REUTERS

Fujifilm launches EB-710US balloon-less EBUS bronchoscope in US market

Enveric net loss narrows to $1.6 million in Q1 FY26; loss per share improves to $1.08

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EXSR"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EXSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXSR\",,,,,undefined,":{"symbol":"EXSR","market":"US","secType":"STK","nameCN":"Exchange Bank (Santa Rosa, CA)","latestPrice":147.4,"timestamp":1779890638969,"preClose":147,"halted":0,"volume":210,"delay":15,"changeRate":0.0027210884353741885,"floatShares":836001,"shares":1714344,"eps":18.592792,"marketStatus":"Trading","change":0.4,"latestTime":"05-27 10:03:58 EDT Delay","open":148,"high":148,"low":147.4,"amount":31017,"amplitude":0.004082,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":18.592792,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779912000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":147,"volumeRatio":0.589873},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXSR\",,,,,undefined,":{"symbol":"EXSR","floatShares":836001,"roa":"0.97%","roe":"9.79%","lyrEps":17.480004,"volumeRatio":0.589873,"shares":1714344,"dividePrice":5.2038,"high":148,"amplitude":0.004082,"preClose":147,"low":147.4,"week52Low":102.8,"pbRate":"0.72","psRate":"2.09","week52High":150.82,"institutionHeld":0,"latestPrice":147.4,"eps":18.592792,"divideRate":0.035304,"volume":210,"delay":15,"ttmEps":18.592792,"open":148,"prevYearClose":130,"prevWeekClose":147,"prevMonthClose":148.363,"prevQuarterClose":145.6,"fiveDayClose":147.05,"twentyDayClose":148,"sixtyDayClose":144.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXSR\",params:#limit:5,,,undefined,":[{"date":"2026-06-05","symbol":"EXSR","amount":1.35,"announcedDate":"2026-05-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-05","defaultRemindTime":1780666200000,"name":"Exchange Bank (Santa Rosa, CA)","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-22","payableDate":"2026-06-05","currency":"USD","dateTimestamp":1780632000000,"payDate":"2026-06-22"},{"date":"2026-03-06","symbol":"EXSR","amount":1.3,"announcedDate":"2026-02-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-06","defaultRemindTime":1772807400000,"name":"Exchange Bank (Santa Rosa, CA)","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-06","currency":"USD","dateTimestamp":1772773200000,"payDate":"2026-03-20"},{"date":"2025-11-28","symbol":"EXSR","amount":1.3,"announcedDate":"2025-11-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-28","defaultRemindTime":1764340200000,"name":"Exchange Bank (Santa Rosa, CA)","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-12","payableDate":"2025-11-28","currency":"USD","dateTimestamp":1764306000000,"payDate":"2025-12-12"},{"date":"2025-09-05","symbol":"EXSR","amount":1.3,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-05","defaultRemindTime":1757079000000,"name":"Exchange Bank (Santa Rosa, CA)","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-05","currency":"USD","dateTimestamp":1757044800000,"payDate":"2025-09-19"},{"date":"2025-06-06","symbol":"EXSR","amount":1.3,"announcedDate":"2025-05-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-06","defaultRemindTime":1749216600000,"name":"Exchange Bank (Santa Rosa, CA)","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-06","currency":"USD","dateTimestamp":1749182400000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXSR\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-01","recordDate":"2016-06-03","paymentDate":"2016-06-17","value":0.7,"currency":"USD"},{"executeDate":"2016-08-31","recordDate":"2016-09-02","paymentDate":"2016-09-16","value":0.7,"currency":"USD"},{"executeDate":"2016-11-22","recordDate":"2016-11-25","paymentDate":"2016-12-09","value":0.75,"currency":"USD"},{"executeDate":"2019-06-06","recordDate":"2019-06-07","paymentDate":null,"value":1.1,"currency":"USD"},{"executeDate":"2019-09-05","recordDate":"2019-09-06","paymentDate":null,"value":1.1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXSR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXSR\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636103855","title":"Enveric says EB-003 shows no phototoxicity risk in preclinical analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2636103855","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636103855?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:01","pubTimestamp":1779192084,"startTime":"0","endTime":"0","summary":"Enveric Biosciences reported positive preclinical phototoxicity results for its lead neuroplastogen candidate EB-003; the results have already been presented.The analysis found no photoreactive potential, supporting a favorable safety profile and reducing development risk for chronic use in neuropsychiatric disorders.The outcome supports plans to move EB-003 into first-in-human Phase 1 clinical trials.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL3Jl11c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXSR","ENVB","BK4007","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636021290","title":"Exchange Bank Announces Promotion of Mindy Smith to Community Relations Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2636021290","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636021290?lang=en_us&edition=fundamental","pubTime":"2026-05-19 07:09","pubTimestamp":1779145740,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nTUA5KLCMH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4211","EXSR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636461078","title":"Fujifilm launches EB-710US balloon-less EBUS bronchoscope in US market","url":"https://stock-news.laohu8.com/highlight/detail?id=2636461078","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636461078?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:57","pubTimestamp":1779105464,"startTime":"0","endTime":"0","summary":"Fujifilm Holdings America Corporation launched the EB-710US endobronchial ultrasound bronchoscope for the US market, targeting faster pulmonary procedure throughput and lower per-case consumable spend.The balloon-less approach aims to reduce reprocessing-related infection risk exposure, a potential differentiator for hospitals tightening quality metrics and cost controls.The product positions Fujifilm to compete more aggressively in EBUS by pairing workflow simplification with imaging performance claims, supporting broader adoption across pulmonology service lines.Fujifilm is showcasing the device at the American Thoracic Society Conference running May 18-20 in Orlando, signaling a push to accelerate clinical trial and purchasing conversations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not b","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL3lK5yF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","EXSR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081107","title":"Enveric net loss narrows to $1.6 million in Q1 FY26; loss per share improves to $1.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081107","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081107?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:01","pubTimestamp":1778846480,"startTime":"0","endTime":"0","summary":"Enveric Biosciences posted a net loss attributable to stockholders of USD 1.6 million, narrowing from USD 2.2 million in first-quarter 2025, while loss per share improved to USD 1.08 from USD 14.58.Cash on hand totaled USD 4.9 million, with USD 2.8 million of gross proceeds raised through offerings during the quarter.As of May 15, 2026, cash balance was about USD 10.3 million following a private placement of up to USD 13.9 million including USD 5 million upfront, with USD 1.5 million raised from warrant exercises.Management said funds are expected to support preclinical development for lead candidate EB-003, planned IND filing, operations into first quarter of fiscal 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enveric Bioscien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL9d8l61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXSR","ENVB","BK4007","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EXSR\",params:#limit:6,delay:false,,,undefined,":[]}}